A three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...
A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...
Help women with ovarian and breast cancer live longer and better lives by supporting the Institute of Cancer Research. Donate ...
Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...
Cancer Research UK (CRUK) has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a ...
Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers. Posted on 16 October, 2024 by ...
Last summer I was diagnosed with testicular cancer. Thankfully it was caught early and I feel lucky, I know that some people go through things that are so much worse. It started when I found a lump ...
Dr Rachael Natrajan leads the Functional Genomics group in the Breast Cancer Now Toby Robins Research Centre at the Institute of Cancer Research. This Breast Cancer Awareness Month, she reveals what ...
Alex Naim, 27, a solution engineer living in London, completed the Royal Parks Half Marathon and raised thousands of pounds for our vital research, even though running is one of his least favourite ...
We’re now 100 days into the new Government and the ICR’s Advocacy Manager, Ollie Richards, outlines what academic institutions need the Government to prioritise to help us on our mission to continue ...
People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower ...
A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ovarian cancer that rarely responds to chemotherapy or hormone therapy. The ...